Related Experiment Videos
A single center experience in preemptive kidney transplantation
A Debska-Slizień1, W Wołyniec, A Chamienia
1Departments of Nephrology, Transplantology and Internal Diseases, Gdańsk Medical University, ul. Debinki 7, 80-211 Gdańsk, Poland. adeb@amg.gda.pl
Transplantation Proceedings
|March 1, 2006
Summary
Preemptive kidney transplantation before dialysis initiation offers significant benefits. This study shows preemptive transplants reduce delayed graft function and improve patient outcomes for end-stage renal disease.
Area of Science:
- Nephrology
- Transplantation Immunology
- Surgical Innovation
Background:
- End-stage renal disease (ESRD) management often involves chronic dialysis, carrying significant morbidity.
- Preemptive kidney transplantation (PKT) aims to bypass the need for dialysis, potentially improving patient quality of life and outcomes.
- Evaluating the efficacy and safety of PKT compared to non-preemptive transplantation is crucial for optimizing ESRD treatment strategies.
Purpose of the Study:
- To assess the outcomes of preemptive kidney transplantation compared to non-preemptive transplantation in ESRD patients.
- To evaluate the impact of PKT on delayed graft function, rejection episodes, and graft/patient survival.
- To analyze patient and donor characteristics in both preemptive and non-preemptive transplant groups.
Main Methods:
- Retrospective analysis of 15 preemptive kidney transplant recipients and a comparison group of non-preemptive recipients from November 2003 to April 2005.
- Comparison of patient demographics, donor characteristics, waiting list times, and immunological parameters (mismatches).
- Assessment of graft function using creatinine clearance and plasma creatinine levels, and evaluation of clinical outcomes including delayed graft function, acute rejection, and survival rates.
Main Results:
- Preemptive recipients had significantly shorter waiting list times (mean 2.4 months vs. 13.8 months).
- Incidence of delayed graft function was significantly lower in the preemptive group (20% vs. 42%).
- No significant differences were observed in acute rejection episodes or graft and patient survival rates between the groups. Post-transplant renal function was better in preemptive recipients.
Conclusions:
- Preemptive kidney transplantation is a promising optimal treatment for ESRD patients, effectively avoiding dialysis-related morbidity.
- PKT demonstrates a lower incidence of delayed graft function and improved early graft function compared to non-preemptive transplantation.
- The study supports the notion that PKT should be considered the preferred approach for eligible ESRD patients, offering comparable long-term survival benefits.